| 1998 |
NHE3 (encoded by Slc9a3) is the major absorptive Na+/H+ exchanger in kidney proximal tubule and intestinal epithelial apical membranes; deletion of NHE3 in mice causes sharply reduced HCO3- and fluid absorption in proximal convoluted tubules, severe intestinal absorptive defect, mild metabolic acidosis, reduced blood pressure, and compensatory upregulation of aldosterone, renin, AE1, colonic H+,K+-ATPase mRNA, and epithelial Na+ channel activity. |
Gene knockout mouse (Slc9a3-/-), in vivo microperfusion, blood analysis, Northern blot, immunohistochemistry |
Nature genetics |
High |
9662405
|
| 1996 |
NHE3 is exclusively restricted to the apical membrane of polarized epithelial cells (and not the basolateral membrane), as demonstrated by functional Na+/H+ exchange measurements, immunofluorescence, confocal microscopy, and cell-surface biotinylation in OK and MDCK cells. |
Stable transfection, immunofluorescence, confocal microscopy, cell-surface biotinylation, functional NHE activity assays |
Journal of cell science |
High |
8743940
|
| 1996 |
NHE2 and NHE3 are both present in brush-border but not basolateral membranes of small intestinal and colonic villus epithelial cells in humans and rabbits, as shown by Western analysis and immunohistochemistry. |
Western blot, immunohistochemistry on human and rabbit intestinal tissue |
The American journal of physiology |
High |
8772498
|
| 1998 |
cAMP-mediated inhibition of NHE3 requires the PDZ-domain adapter proteins NHERF or E3KARP, which bind both NHE3 and ezrin (shown by co-immunoprecipitation), functioning as adapters that localize PKA type II near NHE3 to allow NHE3 phosphorylation; NHERF is phosphorylated basally but not after cAMP treatment, and E3KARP is not phosphorylated. |
Co-immunoprecipitation, in vivo phosphorylation studies, cAMP analog profiling, intracellular pH recovery assays in opossum kidney cells |
The Journal of biological chemistry |
High |
9792717
|
| 1999 |
NHE3 undergoes endocytosis primarily via clathrin-coated pits and vesicles; inhibition of clathrin-mediated endocytosis (by hypertonicity, acid treatment, K+ depletion, or dominant-negative dynamin DynS45N) blocks NHE3 internalization; intracellular trafficking of NHE3 also involves an epsilon-COP-dependent step. |
Immunofluorescence, radiolabeling, dominant-negative dynamin transfection, ldlF temperature-sensitive epsilon-COP mutant cells, isolation of clathrin-coated vesicles from ileal villus cells |
The Journal of biological chemistry |
High |
10608808
|
| 2000 |
PTH acutely inhibits NHE3 in a biphasic manner: early inhibition (5 min) is mediated by NHE3 phosphorylation on multiple serines; late inhibition (30 min) involves dynamin-dependent endocytosis of NHE3 from the surface, as blocking endocytic trafficking with dominant-negative dynamin K44A abrogates late but not early inhibition. |
Dominant-negative dynamin K44A transfection, cell-surface NHE3 antigen detection, NHE3 phosphorylation assays, intracellular pH recovery in opossum kidney cells |
The Journal of biological chemistry |
High |
10866993
|
| 1999 |
In NHE3 null mice, the remaining proximal tubule HCO3- reabsorption is mediated by bafilomycin-sensitive H+-ATPase; NHE2 and other EIPA-sensitive NHE isoforms do not contribute to HCO3- reabsorption in the absence of NHE3, and H+-K+-ATPase activity is undetectable in proximal tubule. |
In situ microperfusion of proximal tubules in NHE3-/- vs. wild-type mice, pharmacological inhibitors (EIPA, bafilomycin, Sch-28080) |
The American journal of physiology |
High |
10444585
|
| 2002 |
NHE3 is the dominant NHE isoform responsible for Na+ absorption in the small intestine; NHE3 knockout mice have markedly reduced net Na+ absorption in jejunum while NHE2 knockout mice do not, demonstrating isoform-specific roles. |
Radioisotopic Na+ and Cl- flux measurements across isolated jejuna from NHE2-/-, NHE3-/-, and wild-type mice; pharmacological inhibition with EIPA; quantitative RT-PCR |
American journal of physiology. Gastrointestinal and liver physiology |
High |
11960774
|
| 1999 |
In vivo PTH administration causes natriuresis by redistributing NHE3 (and NaPi2) from apical membranes to intracellular fractions and inhibiting basolateral Na-K-ATPase; cAMP/PKA signaling is required for NHE3 internalization but not for Na-K-ATPase inhibition. |
In vivo PTH infusion in rats, subcellular membrane fractionation on sorbitol density gradients, immunodetection of NHE3, urinary cAMP measurement |
The American journal of physiology |
High |
10330053
|
| 2000 |
NHERF (but not NHERF2) colocalizes with NHE3 and ezrin in the apical membrane of renal proximal tubule cells, forming a multiprotein signaling complex required for PKA-mediated inhibition of NHE3; NHERF2 colocalizes with ROMK in collecting duct. |
Immunocytochemistry with isoform-specific antibodies in rat kidney, colocalization analysis |
American journal of physiology. Cell physiology |
Medium |
11121391
|
| 2003 |
Angiotensin II stimulates NHE3 activity by PI3-kinase-dependent exocytic insertion of NHE3 protein into the apical membrane (without changing total NHE3), and this requires actin cytoskeleton integrity. |
Cell surface biotinylation, 22Na uptake assays, AT1 receptor antagonists, wortmannin (PI3K inhibitor), latrunculin B (actin inhibitor) in proximal tubular MKCC cells |
Kidney international |
High |
12911544
|
| 2004 |
Initiation of Na+-glucose cotransport (SGLT1 activity) triggers NHE3 translocation to the apical membrane via a pathway requiring p38 MAP kinase activation followed by ezrin phosphorylation at Thr567; dominant-negative ezrin blocks NHE3 recruitment and cytoplasmic pH increases. |
Dominant-negative ezrin construct, p38 MAP kinase inhibitors, live cell pH imaging, confocal microscopy of NHE3 distribution, ezrin phosphorylation assays in intestinal epithelial cells |
Proceedings of the National Academy of Sciences of the United States of America |
High |
15197272
|
| 2004 |
Akt2 directly phosphorylates ezrin at Thr567 to trigger NHE3 translocation to the apical membrane; purified Akt phosphorylates recombinant ezrin in vitro; siRNA knockdown of Akt2 specifically prevents ezrin phosphorylation, NHE3 translocation, and NHE3 activation after Na+-glucose cotransport. |
In vitro kinase assay with purified Akt and recombinant ezrin, siRNA knockdown of Akt2, PI3K inhibitors, pharmacological Akt inhibitors, NHE3 translocation assay |
The Journal of biological chemistry |
High |
15531580
|
| 2005 |
SGK1 phosphorylates NHE3 at Ser663, and this phosphorylation is the key mechanism for glucocorticoid (dexamethasone)-stimulated NHE3 activation; mutation of Ser663 to Ala blocks the dexamethasone effect; phosphorylation precedes increased NHE3 surface expression. |
In vitro SGK1 kinase assay, site-directed mutagenesis (S663A), cell surface NHE3 measurement, NHE3 activity assays |
American journal of physiology. Cell physiology |
High |
15888551
|
| 2006 |
The NHE3 juxtamembrane cytoplasmic domain (aa 475-589) directly binds the FERM domain III of ezrin; a positive amino acid cluster (K516, R520, R527) is necessary for this binding; point mutations abolishing ezrin binding decrease NHE3 surface expression (by reducing exocytosis), decrease brush-border mobility, and reduce NHE3 activity. |
Direct binding assays, site-directed mutagenesis of NHE3 (K516Q, R520F, R527F), cell surface biotinylation, FRAP for mobility measurements, exo/endocytosis rate measurements |
Molecular biology of the cell |
High |
16540524
|
| 2006 |
NHE3 activity and basal endocytosis require lipid raft integrity; ~50% of surface NHE3 resides in lipid rafts; disruption of lipid rafts with methyl-β-cyclodextrin decreases NHE3 activity (Vmax and K'H+i) and basal endocytosis rate without changing surface NHE3 amount; cholesterol repletion reverses these effects. |
Density gradient centrifugation, methyl-β-cyclodextrin treatment, cholesterol repletion, 22Na uptake assays, cell surface biotinylation in opossum kidney (OK) cells |
The Journal of biological chemistry |
High |
16648141
|
| 2006 |
TNF-induced NHE3 internalization from the brush border is mediated by PKCα activation; pharmacological or genetic PKCα inhibition prevents NHE3 internalization, Na+ malabsorption, and diarrhea despite continued barrier dysfunction. |
In vivo mouse model of T cell-mediated diarrhea, PKCα inhibitors, PKCα genetic knockout, NHE3 localization by immunofluorescence |
The Journal of clinical investigation |
High |
17016558
|
| 2000 |
RhoA and Rho-associated kinase (ROK/ROCK) are required for optimal NHE3 activity; dominant-negative RhoA or pharmacological ROK inhibition (Y-27632) depresses NHE3 activity; this pathway acts by controlling myosin light chain phosphorylation and actin cytoskeleton organization. |
Transient transfection of dominant-negative RhoA, Rac1, Cdc42; Y-27632 and dominant-negative ROK; myosin light chain phosphorylation assays; microfluorimetry of NHE3 activity |
The Journal of biological chemistry |
High |
10893221
|
| 1999 |
ETB receptor activation by endothelin-1 increases NHE3 activity by phosphorylating NHE3 on multiple serine and threonine residues; phosphorylation precedes activity increases and is reversed by alkaline phosphatase; ETB but not ETA receptor mediates this phosphorylation. |
Immunoprecipitation of NHE3, phosphoamino acid analysis, alkaline phosphatase treatment, SDS-PAGE mobility shift, NHE3 activity (pHi recovery) in OKP cells expressing ETB or ETA receptors |
The American journal of physiology |
High |
10199826
|
| 1995 |
Acid-induced activation of NHE3 requires src family non-receptor tyrosine kinases; overexpression of Csk (a physiological inhibitor of src kinases) inhibits acid-induced increases in NHE3 activity and NHE3 mRNA abundance; herbimycin A (tyrosine kinase inhibitor) blocks acid-induced NHE3 activation and c-src activation. |
Overexpression of Csk in OKP cells, herbimycin A treatment, c-src activity assays, pHi recovery assays for NHE3 activity |
Proceedings of the National Academy of Sciences of the United States of America |
High |
7541536
|
| 2002 |
Acid-induced activation of NHE3 requires both c-Src and MEK/ERK pathways; dominant-negative c-Src (c-SrcK295M) prevents acid-induced NHE3 activation; MEK inhibitor PD98059 also blocks NHE3 activation by acid; the two pathways are activated independently. |
Dominant-negative c-Src transfection, MEK inhibitor PD98059, immune complex kinase assays for ERK, JNK, c-Src; pHi recovery assay for NHE3 activity |
Kidney international |
High |
12081562
|
| 2002 |
NHE3 supports receptor-mediated endocytosis (RME) in proximal tubule cells and confers cAMP sensitivity to RME; NHE3 activity maintains endosomal pH homeostasis and is required for megalin/cubilin-mediated albumin uptake; NHE3-deficient cells lack cAMP sensitivity of RME. |
Cellular NHE3 knockout/retransfection, endosomal pH measurement, megalin-mediated albumin uptake assays, fluid-phase vs. receptor-mediated endocytosis comparison in opossum kidney cells |
American journal of physiology. Renal physiology |
High |
12167607
|
| 2004 |
NHE3 supports proximal tubular receptor-mediated endocytosis of filtered proteins in vivo; NHE3 inhibition (by EIPA or S-3226) reduces fractional cytochrome c reabsorption ~50% during early proximal microperfusion; NHE3 knockout mice exhibit significantly higher urinary protein excretion. |
In vivo microinfusion with radiolabeled cytochrome c in rats, NHE3 pharmacological inhibitors, urinary protein analysis in NHE3-/- mice |
American journal of physiology. Renal physiology |
High |
15113744
|
| 2007 |
PDZK1 (NHERF3) absence abolishes cAMP- and Ca2+-dependent inhibition of NHE3 in native colonic enterocytes without affecting NHE3 abundance or apical membrane targeting, or hyperosmolarity-induced inhibition; PDZK1 directly binds NHE3 C terminus (aa 588-667). |
PDZK1 knockout mice, fluorometric NHE3 activity assay in isolated colonic crypts, immunohistochemistry, Western blot, co-immunoprecipitation, in vitro binding assays |
The Journal of physiology |
High |
17395628
|
| 2010 |
NHERF2 is necessary for cGMP- and Ca2+-dependent inhibition of NHE3; NHERF1 is necessary for EGF stimulation of NHE3; both NHERF1 and NHERF2 are required for cAMP-dependent inhibition (either alone is sufficient); NHERF1 knockdown reduces basal NHE3 activity while NHERF2 knockdown stimulates it. |
Stable lentiviral shRNA knockdown of NHERF1/NHERF2 in Caco-2/bbe cells, adenoviral NHE3 expression, second messenger-specific NHE3 activity assays |
American journal of physiology. Cell physiology |
High |
21191106
|
| 1996 |
Glucocorticoid regulation of NHE3 is mediated by transcriptional activation; the NHE3 gene (Nhe3) 5'-regulatory region contains a functional glucocorticoid response element that drives reporter gene expression in renal epithelial cells treated with glucocorticoids. |
Genomic library screening, S1 nuclease protection, luciferase reporter assay in transiently transfected OK and LLC-PK1 cells |
The Journal of biological chemistry |
High |
8631855
|
| 1996 |
Glucocorticoid-induced NHE3 activation is mediated by transcriptional upregulation of NHE3 gene; dexamethasone increases NHE3 mRNA abundance 2-3 fold via increased transcription rate (not mRNA stability), as shown by in vitro transcription and mRNA half-life experiments in OKP cells. |
Northern blot, mRNA half-life assay (actinomycin D chase), in vitro transcription run-on assay in OKP cells |
The American journal of physiology |
High |
8769835
|
| 2000 |
G protein subunit Gsα mediates D1-like receptor-induced inhibition of NHE3 activity in renal brush-border membranes directly (independent of cytoplasmic second messengers); Gsα co-immunoprecipitates with NHE3 and co-precipitation increases with GTPγS and fenoldopam treatment; Gβγ dimers have a stimulatory effect on NHE3 activity. |
Renal brush-border membrane vesicle NHE3 activity assays, co-immunoprecipitation with anti-Gsα, anti-Giα, anti-Gβ antibodies, GTPγS/GDP loading |
American journal of physiology. Regulatory, integrative and comparative physiology |
Medium |
10749796
|
| 2002 |
Nitric oxide inhibits NHE3 activity in Caco-2 cells via activation of soluble guanylate cyclase, leading to increased intracellular cGMP and activation of protein kinase G; this pathway is specific to NHE3 (not NHE2) and is independent of PKA and PKC. |
22Na uptake assays, NO donors (SNAP, sodium nitroprusside), guanylate cyclase inhibitors (LY-83583, ODQ), 8-bromo-cGMP, PKG inhibitor KT-5823, PKA inhibitor Rp-cAMPS, PKC inhibitors |
American journal of physiology. Gastrointestinal and liver physiology |
High |
12181191
|
| 2005 |
Flow-dependent modulation of proximal tubule HCO3- reabsorption involves NHE3 activity (in addition to H+-ATPase); flow-induced torque on brush-border microvilli regulates luminal transporter activity through an intact actin cytoskeleton; cytochalasin D (actin disruption) blocks flow-stimulated HCO3- transport. |
In vitro microperfusion of mouse S2 proximal tubules with EIPA, bafilomycin, cytochalasin D; mathematical modeling of microvillus torque; transepithelial PD measurement |
American journal of physiology. Renal physiology |
High |
16144961
|
| 2009 |
Angiotensin II infusion causes NHE3 (and NaPi2, myosin VI, NHERF-1, ezrin, megalin) to redistribute into proximal tubule brush-border microvilli within 20 min; captopril (ACE inhibitor) causes the reverse redistribution; this trafficking increases PT salt reabsorption. |
In vivo ANG II and captopril infusion in rats, confocal microscopy, density gradient membrane fractionation of renal cortex |
American journal of physiology. Renal physiology |
High |
19864301
|
| 2007 |
NHE3 phosphorylation at Ser552 and Ser605 by PKA is physiologically regulated in vivo and in vitro, but phosphorylation at these sites does not directly alter Na+/H+ exchange activity; phosphorylation clearly precedes transport inhibition, dissociating these events. |
In vivo PTH infusion in rats, forskolin/IBMX in OKP cells, phosphospecific monoclonal antibodies to pSer552 and pSer605, 22Na uptake and microvillar membrane vesicle NHE3 activity assays |
American journal of physiology. Renal physiology |
High |
17409282
|
| 2006 |
Acute dexamethasone activation of NHE3 requires SGK1 kinase activity (not new protein synthesis) and a functional glucocorticoid receptor; the acute effect involves nongenomic GR-dependent SGK1 activation preceding NHE3 surface expression increases; chronic regulation (>12h) additionally requires protein synthesis. |
SGK1 kinase activity assays, cycloheximide/actinomycin D, glucocorticoid receptor blocker RU486, NHE3 protein surface expression and activity assays in Caco-2 and OKP cells |
American journal of physiology. Cell physiology |
High |
16971495
|
| 2006 |
Aldosterone inhibits NHE3 and HCO3- absorption in the medullary thick ascending limb through a rapid, nongenomic pathway involving ERK activation; aldosterone activates ERK within 5 min in microdissected MTALs; MEK/ERK inhibitors prevent both ERK activation and NHE3 inhibition; this effect is independent of mineralocorticoid receptor transcriptional activity. |
In vitro microperfusion of rat MTALs, ERK activity assays in microdissected tubules, MEK inhibitors (U-0126, PD-98059), spironolactone, actinomycin D |
American journal of physiology. Renal physiology |
High |
16757729
|
| 2001 |
Dopamine inhibits NHE3 activity via DA1 receptor activation of PKA (phosphorylating NHE3); DA2 receptors alone are insufficient to inhibit NHE3 but synergize with DA1 and alter NHE3 phosphorylation via distinct kinases/phosphatases; DA2 agonists phosphorylate NHE3 on different sites than DA1/PKA. |
NHE3 activity (pHi recovery), PKA/PKC inhibitors, DA1/DA2 specific agonists and antagonists, NHE3 immunoprecipitation and phosphorylation analysis in opossum kidney (OK) cells |
Kidney international |
High |
11135072
|
| 2006 |
MAPKAPK-2 links p38 MAPK to Akt2 activation in the pathway coupling SGLT1 Na+-glucose cotransport to NHE3 translocation; MAPKAPK-2 can directly phosphorylate Akt2 in vitro; siRNA knockdown of MAPKAPK-2 inhibits Akt2 and ezrin phosphorylation and blocks NHE3 translocation. |
siRNA knockdown, in vitro kinase assay (MAPKAPK-2 phosphorylating Akt2-derived peptide), phosphorylation cascade analysis with inhibitors, NHE3 translocation assay |
The Journal of biological chemistry |
High |
16793766
|
| 2009 |
NHE3 localizes predominantly to flotillin-enriched lipid raft domains in renal proximal tubule microvilli (84% of NHE3 in lipid rafts); hypertension redistributes NHE3 to the base of microvilli without changing its lipid raft partitioning; NaPi2 localizes to nonraft domains (69%) and traffics to endosomes under hypertension. |
Cold 1% Triton X-100 extraction, OptiPrep flotation gradients, confocal microscopy, arterial pressure manipulation in anesthetized rats |
American journal of physiology. Cell physiology |
Medium |
19158399
|
| 2015 |
CAII (carbonic anhydrase II) physically binds the C-terminal domain of NHE3 (shown by proximity ligation assay and solid-phase binding assay) and activates NHE3 function; CAII-V143Y (catalytically inactive) and CAII-HEX (cannot bind transporters) mutants fail to activate NHE3, demonstrating that both CAII binding and catalytic activity are required. |
Proximity ligation assay, solid-phase binding assay with GST-fusion constructs, intracellular pH recovery assay, acetazolamide inhibition, co-expression of CAII mutants in proximal tubule cells |
American journal of physiology. Renal physiology |
High |
26041446
|
| 2015 |
NHE3 forms macrocomplexes with NHERF1, IRBIT, and ezrin in the intestinal brush-border membrane; under diabetic conditions these macrocomplexes are disrupted; insulin restores NHE3 activity by reconstituting these macrocomplexes; IRBIT facilitates NHE3-NHERF1 interaction via PKD2-dependent phosphorylation; NHERF1 or IRBIT silencing prevents NHE3 trafficking to the brush-border membrane. |
Co-immunoprecipitation, siRNA silencing, insulin treatment of STZ-diabetic mice, surface expression assay, NHE3 activity measurement, PKD2 inhibition |
The Journal of clinical investigation |
High |
26258413
|
| 2015 |
Recessive loss-of-function mutations in SLC9A3 (NHE3) cause congenital sodium diarrhea; missense mutations in the N-terminal transmembrane transport domain reduce basal surface expression and/or basal transport function without affecting acute regulation. |
Whole-exome sequencing, Sanger sequencing, functional characterization of missense mutations in NHE-null fibroblasts (surface expression and transport activity assays) |
Human molecular genetics |
High |
26358773
|
| 2017 |
Constitutive tubule-specific NHE3 knockout mice (NHE3loxloxCre) show that renal NHE3 is required for blood pressure maintenance and steady-state plasma sodium when dietary NaCl is modified; loss of renal NHE3 blunts Npt2c expression and alters NCC phosphorylation and ENaC abundance. |
Tubule-specific Cre-lox knockout, telemetric blood pressure measurement, dietary NaCl challenge, immunoblotting of downstream transporters |
Kidney international |
High |
28385297
|
| 2015 |
The circadian clock protein Per1 transcriptionally regulates NHE3 and SGLT1 in renal proximal tubule cells; Per1 and CLOCK are detected at the NHE3 promoter by ChIP; blockade of nuclear Per1 entry reduces NHE3 mRNA, protein (membrane and intracellular), and is associated with reduced Na+-K+-ATPase activity. |
Pharmacological Per1 nuclear entry blockade, Per1 siRNA, quantitative RT-PCR, heterogeneous nuclear RNA analysis, chromatin immunoprecipitation (ChIP), immunoblotting in HK-2 cells and mouse renal cortex |
American journal of physiology. Renal physiology |
High |
26377793
|
| 2017 |
SLC9A3 (NHE3) loss in the male reproductive tract causes obstructive azoospermia; CFTR protein expression is dramatically decreased in epididymis and vas deferens of Slc9a3 knockout mice, indicating interdependence between NHE3 and CFTR expression in the male excurrent duct epithelium. |
Slc9a3 knockout mouse model, immunoblotting, immunohistochemistry, electron microscopy of epididymis/vas deferens epithelium |
PLoS genetics |
Medium |
28384194
|
| 2019 |
Proximal tubule-specific NHE3 deletion (PT-Nhe3-/-) attenuates Ang II-induced hypertension and improves pressure-natriuresis response; Ang II hypertension is completely blocked by AT1 receptor antagonism in both WT and PT-Nhe3-/- mice, placing NHE3 downstream of AT1 receptor signaling in proximal tubule. |
SGLT2-Cre/Nhe3loxlox proximal tubule-specific knockout, Ang II infusion (high and slow pressor), telemetric blood pressure, pharmacological AT1 blockade with losartan, NHE3 inhibitor AVE0657 |
Hypertension (Dallas, Tex. : 1979) |
High |
31352824
|
| 2020 |
Intestinal epithelial cell-specific inducible NHE3 knockout (NHE3IEC-KO) mice develop watery alkaline diarrhea, metabolic acidosis, hyponatremia, hyperkalemia, and markedly elevated aldosterone, demonstrating that intestinal NHE3 is essential for acid-base, Na+, and volume homeostasis. |
Tamoxifen-inducible intestinal epithelial cell-specific Cre-lox knockout, blood gas analysis, electrolyte measurements, aldosterone measurement, intestinal histology |
Clinical science (London, England : 1979) |
High |
32227118
|
| 2009 |
NHE3 is present on the apical membrane of rat cholangiocytes; NHE3-/- mouse bile duct units fail to absorb secreted fluid after forskolin stimulation, establishing a functional role for NHE3 in cholangiocyte fluid absorption. |
Immunocytochemistry, Western blot, isolated bile duct unit videomicroscopy in NHE3-/- mice, NHE inhibitor EIPA |
American journal of physiology. Gastrointestinal and liver physiology |
High |
11208547
|
| 2009 |
NHERF3/PDZK1 directly binds NHE3 C-terminus (aa 588-667) in vitro and co-localizes with NHE3 at brush border in vivo (Co-IP, FRET); elevated [Ca2+]i dissociates NHE3-NHERF3 complexes and inhibits NHE3 Vmax; NHERF3 shRNA knockdown reduces basal NHE3 activity and brush-border NHE3 amount in Caco-2BBe cells. |
In vitro binding assay with C-terminal NHE3 fragments, co-immunoprecipitation, FRET, confocal microscopy, shRNA knockdown, Ca2+ ionophore treatment, NHE3 surface expression assay |
The Journal of biological chemistry |
High |
19535329
|
| 1999 |
Thyroid hormone (T3) stimulates NHE3 activity by transcriptional activation of the NHE3 gene, increasing NHE3 mRNA and protein abundance; T3 has no effect on NHE3 mRNA stability or protein stability/translation, and requires de novo transcription and translation. |
NHE3 activity assays, transcription/translation inhibitors (actinomycin D, cycloheximide), NHE3 mRNA stability assay, run-on transcription, surface and total NHE3 protein measurement, constitutive promoter-driven NHE3 construct as control |
The American journal of physiology |
High |
9886925
|
| 2004 |
D3 dopamine receptor-mediated inhibition of NHE3 in SHR proximal tubular cells requires Giα3 protein coupling and is transduced via PLC-PKC pathway (not PKA); pertussis toxin, PLC inhibitor U-73122, and PKC downregulation all block the D3-mediated NHE3 inhibition; elevated intracellular Ca2+ modulates this pathway. |
Isoform-specific G protein antibody pretreatment, pertussis toxin, cholera toxin, PLC inhibitor, PKC inhibitors/downregulation, NHE3 activity assays in SHR proximal tubule cells |
American journal of physiology. Renal physiology |
Medium |
15265766
|
| 2020 |
Empagliflozin (SGLT2 inhibitor) inhibits proximal tubular NHE3 activity and its natriuretic effect depends on tubular NHE3; empagliflozin had no natriuretic effect in NHE3-ko mice; in diabetic Akita mice, empagliflozin enhanced NHE3 phosphorylation at S552/S605, linked to reduced NHE3 reabsorption. |
Tubule-specific NHE3 knockdown mice, urinary electrolyte measurement, urine pH, empagliflozin treatment, phospho-NHE3 immunoblotting |
American journal of physiology. Renal physiology |
High |
32893663
|